Birwelco USA

Pharmaceuticals and Food

The return on investment in the pharmaceutical industry is under increasing pressure from price restraints, the rising cost of product development and more stringent regulatory requirements. As a result, investment proposals for new manufacturing facilities have to show improved returns, either by generating more for the same money or achieving the same for less.

Unit Birwelco is uniquely placed to help clients maximise their return on investment by providing a wide range of expert support services and packages including:

  • Product development
  • Process development and transfer
  • Scale up and process technology changes
  • Site to site transfers and product relocation
  • Research and development to commercial production transfer

Unit Birwelco’s engineering division offers a broad range of integrated solutions with a single point of contact.

Featured Projects


  • Primary Production Plant
    PPL Therapeutics, UK

  • Hygienic Blending Plant
    Croda, UK

  • Primary Production Plant
    Astra Zeneca, UK

  • Primary Production Plant
    Eli Lilly, UK

  • Cosmetic Protein Plant
    Croda, UK

  • Primary Production Plant
    Astra Zeneca, UK

“Unit Birwelco is uniquely placed to help clients maximise their return on investment by providing a wide range of expert support services and packages.”

Latest News